[{"address1": "3060 Pegasus Park Drive", "address2": "Building 6", "city": "Dallas", "state": "TX", "zip": "75247", "country": "United States", "phone": "310 618 6994", "website": "https://www.fortebiorx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul A.  Wagner Ph.D.", "age": 55, "title": "CEO, President & Chairman", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1030848, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Antony A. Riley CPA", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 652090, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Barbara K. Finck M.D.", "age": 78, "title": "Chief Medical Clinician & Director", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 488057, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Roenfeldt", "title": "Chief Operating Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 32.0, "open": 31.76, "dayLow": 30.5, "dayHigh": 33.29, "regularMarketPreviousClose": 32.0, "regularMarketOpen": 31.76, "regularMarketDayLow": 30.5, "regularMarketDayHigh": 33.29, "payoutRatio": 0.0, "beta": 3.219, "forwardPE": -8.43469, "volume": 411587, "regularMarketVolume": 411587, "averageVolume": 148405, "averageVolume10days": 206280, "averageDailyVolume10Day": 206280, "bid": 31.25, "ask": 32.39, "bidSize": 1, "askSize": 1, "marketCap": 399609216, "fiftyTwoWeekLow": 4.9, "fiftyTwoWeekHigh": 35.46, "allTimeHigh": 6732.375, "allTimeLow": 4.11, "fiftyDayAverage": 23.0918, "twoHundredDayAverage": 13.81889, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 306195232, "profitMargins": 0.0, "floatShares": 6650550, "sharesOutstanding": 12526935, "sharesShort": 511832, "sharesShortPriorMonth": 129120, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.040900003, "heldPercentInsiders": 0.03968, "heldPercentInstitutions": 0.96823996, "shortRatio": 3.28, "shortPercentOfFloat": 0.0484, "impliedSharesOutstanding": 12526935, "bookValue": 4.717, "priceToBook": 6.762773, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -51742000, "trailingEps": -0.08, "forwardEps": -3.782, "lastSplitFactor": "1:25", "lastSplitDate": 1724803200, "enterpriseToEbitda": -5.736, "52WeekChange": 1.0997376, "SandP52WeekChange": 0.14987159, "quoteType": "EQUITY", "currentPrice": 31.9, "targetHighPrice": 75.0, "targetLowPrice": 54.0, "targetMeanPrice": 63.75, "targetMedianPrice": 63.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 93414000, "totalCashPerShare": 7.457, "ebitda": -53382000, "totalDebt": 0, "quickRatio": 7.231, "currentRatio": 7.344, "returnOnAssets": -0.58066005, "returnOnEquity": -1.10722, "freeCashflow": -24480124, "operatingCashflow": -44425000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "FBRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1769202604, "regularMarketTime": 1769202001, "marketState": "CLOSED", "shortName": "Forte Biosciences, Inc.", "longName": "Forte Biosciences, Inc.", "exchange": "NCM", "messageBoardId": "finmb_594626683", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.312501, "regularMarketPrice": 31.9, "fiftyTwoWeekChangePercent": 109.97376, "dividendDate": 1592265600, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.08, "epsForward": -3.782, "epsCurrentYear": -4.316, "priceEpsCurrentYear": -7.391103, "fiftyDayAverageChange": 8.808199, "fiftyDayAverageChangePercent": 0.3814427, "twoHundredDayAverageChange": 18.08111, "twoHundredDayAverageChangePercent": 1.3084344, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1492090200000, "postMarketChangePercent": 0.0, "postMarketPrice": 31.9, "postMarketChange": 0.0, "regularMarketChange": -0.1, "regularMarketDayRange": "30.5 - 33.29", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 148405, "fiftyTwoWeekLowChange": 27.0, "fiftyTwoWeekLowChangePercent": 5.510204, "fiftyTwoWeekRange": "4.9 - 35.46", "fiftyTwoWeekHighChange": -3.5599995, "fiftyTwoWeekHighChangePercent": -0.1003948, "displayName": "Forte Biosciences", "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]